Anika Therapeutics buy Barrington Research

Summary

This prediction ended on 23.10.25 with a price of €8.20. The BUY prediction by Barrington_Research for Anika Therapeutics performed very badly with a performance of -64.04%. Barrington_Research has a follow-up prediction for Anika Therapeutics where he still thinks Anika Therapeutics is a Buy. Barrington_Research has 50% into this prediction

Performance without dividends (%)

Name	1w	1m	1y
Anika Therapeutics	9.202%	9.202%	138.926%
iShares Core DAX®	0,63 %	4,95 %	8,66 %
iShares Nasdaq 100	1,16 %	-1,16 %	26,82 %
iShares Nikkei 225®	2,36 %	-1,35 %	48,19 %
iShares S&P 500	0,63 %	1,38 %	22,99 %